Exchange Bank’s AbbVie ABBV Stock Holding History

Exchange Bank’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.07M	Sell	4,093 -52	-1%	-$13.3K	0.66%	41
2026 Q2	$1.04M	Buy	4,145 +1,975	+91%	+$425K	0.65%	43
2026 Q1	$472K	Hold	2,170	–	–	0.33%	82
2025 Q4	$496K	Sell	2,170 -6	-0.3%	-$1.37K	0.34%	80
2025 Q3	$504K	Buy	2,176 +200	+10%	+$40.7K	0.35%	83
2025 Q2	$367K	Hold	1,976	–	–	0.29%	90
2025 Q1	$414K	Buy	1,976 +37	+2%	+$7.19K	0.33%	79
2024 Q4	$345K	Hold	1,939	–	–	0.28%	87
2024 Q3	$383K	Hold	1,939	–	–	0.31%	82
2024 Q2	$333K	Sell	1,939 -28	-1%	-$4.64K	0.28%	81
2024 Q1	$358K	Sell	1,967 -17	-0.9%	-$2.93K	0.29%	78
2023 Q4	$307K	Sell	1,984 -385	-16%	-$56.1K	0.27%	87
2023 Q3	$353K	Sell	2,369 -59	-2%	-$8.66K	0.34%	72
2023 Q2	$327K	Buy	+2,428	New	+$356K	0.32%	77

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

Cardano Risk Management Rotterdam, Netherlands $18.2B AUM 38.97% 1-Year Est. Return

Sepio Capital Salt Lake City, Utah $2.5B AUM 20.77% 1-Year Est. Return

Exchange Bank's ABBV Position: Q3 2026 in Review

Exchange Bank reduced its AbbVie (ABBV) stake by 1.3% in Q3 2026, selling an estimated $13.3K and leaving 4,093 shares worth $1.07M. The position accounts for 0.66% of the portfolio, ranked #41.

Exchange Bank first reported a position in ABBV in Q2 2023 and has held it in 14 quarters since. 1,816 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

Exchange Bank held 4,093 shares of AbbVie worth $1.07M as of Q3 2026.
Exchange Bank sold 52 AbbVie shares in Q3 2026, an estimated $13.3K.
AbbVie made up 0.66% of Exchange Bank's portfolio in Q3 2026, its #41 holding.
Exchange Bank first reported a position in AbbVie in Q2 2023 and has held it in 14 quarters since.
1,816 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Exchange Bank's 13F filing for Q3 2026, filed 7 Oct 2026.